Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl. 2024

Swati Bhardwaj, and Natalie Banet, and Emily C Gaston

Sertoli-Leydig cell tumors (SLCT) are rare tumors of the ovary with a peak incidence in the second to third decade of life. Serous borderline tumors (SBT) are epithelial ovarian neoplasms which occur at a median age of 50 years. A co-occurrence of SLCT and SBT has not yet been reported. Here, we describe a case of a 16-year-old girl who presented with irregular menses, virilization, and an abdominopelvic mass. The mass was surgically removed and an intraoperative consultation revealed an 18.5 cm solid and cystic ovarian mass with the presence of co-existing SLCT and SBT. The diagnosis was confirmed on permanent sections after extensive sampling and immunohistochemical stains. The SLCT showed positive staining for calretinin, inhibin, CD99, and androgen receptor. MART-1 immunostain highlighted the Leydig cells. The SBT showed classic features including hierarchically branching papillae lined by stratified serous epithelium. This pediatric case is the first reported case of a Sertoli-Leydig cell tumor arising in association with a serous borderline tumor.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D018293 Cystadenoma, Serous A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972) Cystadenomas, Serous,Serous Cystadenoma,Serous Cystadenomas
D018310 Sertoli-Leydig Cell Tumor A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS. Androblastoma,Arrhenoblastoma,Sertoli-Leydig Cell Tumors,Androblastomas,Arrhenoblastomas,Cell Tumor, Sertoli-Leydig,Cell Tumors, Sertoli-Leydig,Sertoli Leydig Cell Tumor,Sertoli Leydig Cell Tumors,Tumor, Sertoli-Leydig Cell,Tumors, Sertoli-Leydig Cell

Related Publications

Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
January 2020, Journal of Indian Association of Pediatric Surgeons,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 2016, Oncology letters,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
January 2013, Case reports in obstetrics and gynecology,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 2016, Scottish medical journal,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 1996, Journal of Korean medical science,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
October 2014, Archives of gynecology and obstetrics,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 2010, Journal of pediatric and adolescent gynecology,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
February 2009, The journal of obstetrics and gynaecology research,
Swati Bhardwaj, and Natalie Banet, and Emily C Gaston
July 2023, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Copied contents to your clipboard!